Business

Blocklisting Interim Review

Blocklisting Interim Review.

articleOxford Biomedica PlcJanuary 4, 20163/company/oxford-biomedica-plc/news/blocklisting-interim-review-198
Blocklisting Interim Review

About this update from Oxford Biomedica Plc

[{"type":"text","content":"\n \nRNS Number : 6391K Oxford Biomedica PLC 04 January 2016  \n\n\n\n\n\nFor Immediate Release\n\n\n4 January 2016\n\n\n\n\n \nOXFORD BIOMEDICA PLC\n \nBLOCK LISTING RETURN\n \n\n\n\n\nName of applicant:\n\n\nOXFORD BIOMEDICA PLC\n\n\n\n\nName of scheme:\n\n\n2015 Employee Share Option Scheme\n\n\n\n\nPeriod of return:\n\n\nFrom:\n\n\n30 June 2015\n\n\nTo:\n\n\n31 December 2015\n\n\n\n\nBalance of unallotted securities under scheme(s) from previous return:\n\n\n6,845,803\n\n\n\n\nPlus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):\n\n\nNIL\n\n\n\n\nLess:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):\n\n\n523,287\n\n\n\n\nEquals:  Balance under scheme(s) not yet issued/allotted at end of period:\n\n\n6,322,516\n\n\n\n\n\n\n\n\n\n\n\n \n \n\n\n\n\nName of applicant:\n\n\nOXFORD BIOMEDICA PLC\n\n\n\n\nName of scheme:\n\n\n2015 Long Term Incentive Plan\n\n\n\n\nPeriod of return:\n\n\nFrom:\n\n\n30 June 2015\n\n\nTo:\n\n\n31 December 2015\n\n\n\n\nBalance of unallotted securities under scheme(s) from previous return:\n\n\n26,850,000\n\n\n\n\nPlus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):\n\n\nNIL\n\n\n\n\nLess:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):\n\n\n5,110,000\n\n\n\n\nEquals:  Balance under scheme(s) not yet issued/allotted at end of period:\n\n\n21,740,000\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n\n\n\n\nName of contact:\n\n\nTim Watts\n\n\n\n\nTelephone number of contact:\n\n\n01865 783000\n\n\n\n\n \n \n \n\nThis information is provided by RNSThe company news service from the London Stock Exchange  END  BLRKMGGMMFZGVZZ\n ","length":7788,"tagName":"div"}]

More updates from Oxford Biomedica Plc